These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2573209)

  • 21. Hemodynamic effects of H2-receptor antagonists.
    Iberti TJ
    DICP; 1990 Nov; 24(11 Suppl):S35-7. PubMed ID: 1980182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration.
    Jones LA; Gonzalez ER; Reines HD; Venitz J
    Ann Pharmacother; 1994; 28(7-8):841-4. PubMed ID: 7949496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
    Ostro MJ
    Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.
    Cook DJ; Reeve BK; Guyatt GH; Heyland DK; Griffith LE; Buckingham L; Tryba M
    JAMA; 1996 Jan 24-31; 275(4):308-14. PubMed ID: 8544272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.
    Segal R; Oh T; Ben-Joseph R; Russell WL
    Hosp Formul; 1994 May; 29(5):379-82, 388-91. PubMed ID: 10136601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroesophageal reflux and histamine2 antagonists.
    Bell SG
    Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
    Alekseenko SA; Timoshin SS
    Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influencing parenteral histamine2-receptor antagonist use.
    Sesin GP; Provost PS; O'Keefe EM
    DICP; 1989 Oct; 23(10):812. PubMed ID: 2573203
    [No Abstract]   [Full Text] [Related]  

  • 32. What are the differences between the H2-receptor antagonists?
    Schunack W
    Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
    Feldman M
    JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of H2-receptor blockers (cimetidine and ranitidin) on parotid gland secretion and salivary carbonic anhydrase activity in the rat].
    Boros I; Keszler P; Szombath D; Pósch E
    Fogorv Sz; 1993 Aug; 86(8):265-73. PubMed ID: 7902302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomic aspects and formulary considerations related to histamine2-receptor antagonists.
    Souney PF; Stoukides CA
    DICP; 1989 Oct; 23(10 Suppl):S29-35. PubMed ID: 2573207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stress-related mucosal damage: review of drug therapy.
    Vorder Bruegge WF; Peura DA
    J Clin Gastroenterol; 1990; 12 Suppl 2():S35-40. PubMed ID: 1978844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.